YourBio Health

# YourBio Health: Revolutionizing Blood Collection Through Painless Sampling Technology

High-Level Overview

YourBio Health is a medical device company that has invented and commercialized Touch-Activated Phlebotomy (TAP), a virtually painless blood collection technology.[1] The company develops high-volume capillary blood collection devices that eliminate the pain and anxiety associated with traditional venipuncture and fingerstick tests, serving three primary markets: decentralized clinical trials, wellness testing, and clinical-grade blood sampling in professional healthcare settings.[1][3]

The core problem YourBio Health addresses is significant: nearly 30% of American patients skip medical treatments due to anxiety, pain, and discomfort from intravenous blood draws.[5] By replacing traditional needles with proprietary microneedle technology, the company enables remote, at-home blood collection while maintaining sample quality and volume—up to 900 microliters of whole capillary blood.[3] This positions YourBio Health at the intersection of patient experience improvement and the broader shift toward decentralized healthcare and clinical trial infrastructure.

Origin Story

YourBio Health's TAP technology was invented in 2007 within Flagship Pioneering's Venture Labs, with the original mission to decentralize blood-based testing by enabling sample collection in any location with less pain.[1] The company is a Flagship Pioneering portfolio company, meaning it benefits from the venture studio's scientific expertise, operational support, and network within the life sciences ecosystem.[2]

The founding insight was elegant: if blood collection could be made painless and location-agnostic, it would unlock new possibilities for clinical research, home-based diagnostics, and wellness testing. Early validation came through real-world deployments—the technology was employed to collect capillary blood from 2-month-old infants for antibody tests and demonstrated feasibility in colorectal cancer screening, where it was found to be "the most reliable method and is preferred by patients over venipuncture and lancet sampling" at Erasmus MC.[3] A study with Boston Children's Hospital showed patients and parents chose the TAP Device over traditional venipuncture and lancet 80% of the time.[5]

Core Differentiators

Proprietary HALO™ Technology

• Bladeless microneedle array with needles thinner than an eyelash[5]
• Microneedles pierce only ~1mm deep, remaining above the dermis where nerve endings are located, eliminating the major source of pain[7]
• Needles retract after approximately 3 milliseconds; a gentle vacuum then facilitates blood draw from capillaries[7]
• FDA 510(k) cleared and CE marked for regulatory compliance[5]

Product Flexibility

• TAP® Micro and TAP® Micro Select devices accommodate multiple sample tube types and customizable configurations[3]
• Produces consistently high-quality whole blood samples at volumes up to 900 microliters[3]
• Enables self-collection, reducing dependency on trained phlebotomists and supporting decentralized workflows[1]

Market Validation

• Successfully deployed across diverse patient populations—from infants to adults with various conditions[3]
• Demonstrated high patient acceptance and compliance in clinical trial settings[2]
• Supported by strong regulatory evolution, with expanded CE marking approval announced in October 2023[2]

Integrated Service Offering

• Beyond devices, YourBio Health provides customizable sample management services including kitting, fulfillment, and tracking from end user to central lab[3]

Role in the Broader Tech Landscape

YourBio Health is riding several converging trends that amplify its relevance:

Decentralization of Healthcare: The shift toward remote patient monitoring, home-based diagnostics, and decentralized clinical trials is accelerating. Traditional blood collection infrastructure—requiring patients to visit phlebotomy centers—creates friction. YourBio's technology removes this barrier, enabling trials and diagnostics to scale without geographic constraints.[2]

Patient Experience as Competitive Advantage: Healthcare providers increasingly recognize that patient experience drives compliance and outcomes. With nearly 30% of patients avoiding medical treatments due to needle anxiety, painless blood collection becomes a meaningful differentiator for diagnostic companies, wellness platforms, and clinical trial sponsors.[5]

Regulatory Tailwinds: The regulatory environment has evolved to support remote capillary blood collection, as evidenced by FDA clearance and CE marking. This creates a window for companies with validated technology to capture market share before competitors emerge.[2]

Wellness and Direct-to-Consumer Testing: The growth of at-home health testing and wellness diagnostics creates demand for user-friendly, painless collection methods. YourBio's devices are particularly well-suited for this segment, where ease of use directly impacts adoption.[1]

Quick Take & Future Outlook

YourBio Health has solved a genuine pain point—both literally and figuratively—in an industry where patient experience has historically been an afterthought. The company's patented technology, regulatory approvals, and demonstrated clinical validation position it as a credible player in the decentralized testing ecosystem.

The company's trajectory suggests expansion across three vectors: deeper penetration in clinical trials (where decentralization is a strategic priority for sponsors), growth in the wellness and direct-to-consumer diagnostics space, and adoption in professional healthcare settings seeking to improve patient outcomes. As healthcare continues to shift toward remote and home-based care, technologies that reduce friction and pain become infrastructure—and YourBio Health has built something that addresses both.

The recent acquisition by Hims & Hers (announced in 2025) signals confidence in the technology's market potential and suggests the company will accelerate commercialization within a larger telehealth and direct-to-consumer health platform.[4] This integration could amplify YourBio's reach significantly, embedding painless blood collection into a broader ecosystem of accessible healthcare services.